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Abstract
Background: High-tidal-volume mechanical ventilation and hyperoxia used in patients with acute lung injury (ALI)
can induce the release of cytokines, including high-mobility group box-1 (HMGB1), oxygen radicals, neutrophil
infiltration, and the disruption of epithelial and endothelial barriers. Hyperoxia has been shown to increase
ventilator-induced lung injury, but the mechanisms regulating interaction between high tidal volume and
hyperoxia are unclear. We hypothesized that subcutaneous injections of enoxaparin would decrease the effects of
hyperoxia on high-tidal-volume ventilation-induced HMGB1 production and neutrophil infiltration via the serine/
threonine kinase/protein kinase B (Akt) pathway.
Methods: Male C57BL/6, either wild type or Akt
+/-, aged between 6 and 8 weeks, weighing between 20 and 25 g,
were exposed to high-tidal-volume (30 ml/kg) mechanical ventilation with room air or hyperoxia for 2 to 8 hours
with or without 4 mg/kg enoxaparin administration. Nonventilated mice served as a control group. Evan blue dye,
lung wet-to-dry weight ratio, free radicals, myeloperoxidase, Western blot of Akt, and gene expression of HMGB1
were measured. The expression of HMGB1 was studied by immunohistochemistry.
Results: High-tidal-volume ventilation using hyperoxia induced microvascular permeability, Akt activation, HMGB1
mRNA expression, neutrophil infiltration, oxygen radicals, HMGB1 production, and positive staining of Akt in
bronchial epithelium. Hyperoxia-induced augmentation of ventilator-induced lung injury was attenuated with Akt
deficient mice and pharmacological inhibition of Akt activity by enoxaparin.
Conclusion: These data suggest that enoxaparin attenuates hyperoxia-augmented high-tidal-volume ventilation-
induced neutrophil influx and HMGB1 production through inhibition of the Akt pathway. Understanding the
protective mechanism of enoxaparin related with the reduction of HMGB1 may help further knowledge of the
effects of mechanical forces in the lung and development of possible therapeutic strategies involved in acute lung
injury.
Introduction
Acute respiratory distress syndrome (ARDS)/acute lung
injury (ALI) is characterized by noncardiogenic pulmon-
ary edema, the release of cytokines, and the influx of neu-
trophils [1]. The management of ARDS often requires the
use of mechanical ventilation with high levels of oxygen
to maintain adequate blood oxygenation. Concurrent
hyperoxia and high tidal volume (VT) mechanical ventila-
tion may interact to promote worsening acute lung injury
and lead to the production of inflammatory cytokines,
including macrophage inflammatory protein-2 (MIP-2),
tumor necrosis factor-a (TNF-a), plasminogen activator
inhibitor-1 (PAI-1), and high-mobility group box-1
(HMGB1) [2-5].
In previous studies of ventilator-induced lung injury
(VILI) in mice and rats, hyperoxia was involved in the
pathogenesis of alveolar inflammation and was charac-
terized by lung edema, sequestration of neutrophils,
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any medium, provided the original work is properly cited.destruction of type II alveolar epithelial cells, prominent
intraalveolar deposition of fibrin and cell debris, the
classical feature of hyaline membrane disease [3,6]. The
major oxidants in airways are reactive oxygen species,
including superoxide, hydrogen peroxide, and hydroxyl
radical. Reactive oxygen species may overwhelm the
protection of antioxidants in acute lung injury [7,8].
HMGB1 is expressed in various cells, including macro-
phages/monocytes, endothelial cells, neutrophils, epithelial
cells, dendritic cells, and smooth muscle cells [9]. Because
HMGB1 is present in most cell types and can be passively
released from necrotic cells, it may be released into
bronchoalveolar lavage fluid from injured epithelial cells in
VILI [10,11]. HMGB1 can stimulate the release of cyto-
kines, and conversely, cytokines can control the further
release of HMGB1 to the extracellular space. During endo-
toxemia HMGB1 rises in the circulation starting at 8
hours, increasing until 16 hours, and thereafter remains at
a high level until 36 h [12]. Although it is a late mediator
of lung injury, HMGB1 might express its toxicity in a short
period of time in VILI [10], even in patients without pre-
vious lung injury [13]. High-tidal-volume mechanical venti-
lation can also lead to increase of HMGB1 production,
recruitment of neutrophils, and the development of acute
lung injury involving activation of phosphoinositide 3-OH
kinase (PI 3-K) and serine/threonine kinase/protein kinase
B (Akt) in an isolated mouse model of endotoxemia [14].
Enoxaparin, one of the low-molecular-weight heparins
(LMWHs), is safer and easier to administer than unfractio-
nated heparin, a naturally occurring glycosaminoglycan
with both anticoagulant and anti-inflammatory activities
[15]. Low dose of LMWH was found in a murine acute
lung injury model to have protective effects due to its
effects on neutrophil emigration, edema formation, and
PAI-1 production [16]. No significant side effects of airway
bleeding were found. Dixon and coworkers showed that
nebulized heparin was associated with fewer days of
mechanical ventilation in critically ill patients but the
mechanism was unclear [17]. In this high-tidal-volume
ventilation-induced acute lung injury model in mice with
hyperoxia, we explored the effects of low dose of LMWH
on high-tidal-volume ventilation-induced neutrophil infil-
tration and correlation of acute lung injury to the produc-
tion of HMGB1 and the activation of Akt signaling using
animals deficient in Akt. We hypothesized that subcuta-
neous injections of enoxaparin would decrease neutrophil
influx, lung edema, and HMGB1 production in mice
exposed to high-tidal-volume ventilation with hyperoxia
via Akt pathway.
Materials and methods
Experimental animals
Male C57BL/6, either wild type or Akt
+/- on a C57BL/6
background, weighing between 20 and 25 g, aged between
6 and 8 weeks, were obtained from Jackson Laboratories
(Bar Harbor, ME) and National Laboratory Animal Center
(Taipei, Taiwan) as previously described [18]. Briefly, Het-
erozygotes are used because homozygotes exhibit lower
fertility and female homozygotes do not nurse well; up to
50% perinatal mortality can occur. Mice that are heterozy-
gous for the targeted mutation are viable and do not dis-
play any gross behavioral abnormalities. The construct
Akt containing disrupted exons 4 through 7 and the 5’end
of exon 8 is electroporated into 129P2Ola/Hsd derived
E14 embryonic stem cells. Chimeras are generated by
injecting these ES cells into C57BL/6 (B6) blastocysts. The
resulting chimeric male animals are crossed to C57BL/6
mice, and then backcrossed to the same for 10 genera-
tions. Heterozygotes are intercrossed to generate homozy-
gous mutant mice. In our murine model of ALI, we used
male mice to decrease the effects of estrous cycles found
in female mice [6]. The lower expressions of the Akt pro-
tein in Akt
+/- mice were confirmed using Western blot
analysis. The study was performed in strict accordance
with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional
Animal Care and Use Committee of Chang Gung Memor-
ial Hospital (Permit Number: 2008090102). All surgery
was performed under ketamine and xylazine anesthesia,
and all efforts were made to minimize suffering.
Ventilator Protocol
We used our established mouse model of VILI, as pre-
viously described [6]. In brief, tracheostomy was per-
formed under general anesthesia with intraperitoneal
ketamine (90 mg/kg) and xylazine (10 mg/kg) followed by
ketamine (0.1 mg/g/h) and xylazine (0.01 mg/g/h) at a rate
of 0.09 ml/10 g/h by a continuous intraperitoneal infusion.
The mice were placed in a supine position on a heating
blanket and then attached to a Harvard apparatus ventila-
tor, model 55-7058 (Harvard Apparatus, Holliston, MA),
set to deliver 30 ml/kg at a rate of 65 breaths per minute,
for 2 to 8 hours while breathing room air or hyperoxia
(> 95% oxygen) with zero end-expiratory pressure. Oxygen
was fed into the inspiratory port of the ventilator when
needed. Spontaneously breathing animals were exposed to
hyperoxia in an enclosed chamber as previously described
[2]. Two hours of mechanical ventilation for RT-PCR and
Western blot and 8 hours for HMGB1 production, free
radicals, and immunohistochemical analysis were used
based on our time-course and previous studies [12]. The
tidal volume delivered by the ventilator was checked by
fluid displacement from an inverted calibration cylinder.
Continuous monitoring of end-tidal CO2 by a microcap-
nograph (Columbus Instruments, Columbus, OH) was
performed, and respiratory frequencies of 65 breaths per
minute for 30 ml/kg were chosen in the experiment, with
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pressure was measured with a pressure-transducer ampli-
fier (Gould Instrument Systems, Valley View, OH) con-
nected to the tubing at the proximal end of the
tracheostomy. Mean arterial pressure was monitored every
hour during mechanical ventilation by using the same
pressure-transducer amplifier connected to a 0.61-mm
outer diameter (0.28-mm inner diameter) polyethylene
catheter ending in the common carotid artery. At the end
of the study period, heparinized blood was taken from the
arterial line for analysis of arterial blood gas, and the mice
were sacrificed. Control, nonventilated mice were anesthe-
tized and sacrificed immediately. The experimental design
and numbers of animals per group is summarized in
Table 1.
Enoxaparin administration
Low dose of enoxaparin (Sigma, St. Louis, MO), 4 mg/kg,
was given subcutaneously 30 minutes before ventilation,
based on our previous in vivo study that showed 4 mg/kg
enoxaparin inhibited blood coagulation and lung injury
without significant bleeding tendency [16].
Isolation of intrapulmonary neutrophils
The lungs were minced finely, and incubated in RPMI
1640 with 10 mM HEPES, 20 mM L-glutamine, 10% fetal
cuff serum, 1% penicillin-streptomycin, 20 U/ml of col-
lagenase, and 1 μg/ml of type I DNase (Sigma, St. Louis,
MO) [19]. After incubation for 60 minutes at 37°C on a
rotary agitator, any remaining intact tissue was disrupted
by passage through a 21-gauge needle. Tissue fragments
and the majority of dead cells were removed by rapid fil-
tration through a filtration tube (Sigma, St. Louis, MO),
and cells collected by centrifugation. Intrapulmonary neu-
trophils were isolated using the anti-Ly-6G microbead
neutrophil isolation kit with high purities of more than
95% of neutrophils (Miltenyi Biotec Inc., Auburn, CA).
The cell pellet was flash frozen for the Western blot
analysis.
Evans Blue Dye Analysis
Extravasation of Evans blue dye (Sigma Chemical, St.
Louis, MO) into the interstitium was used as a quantita-
tive measure of changes of microvascular permeability
in acute lung injury [6]. Thirty minutes before end of
mechanical ventilation, 30 mg/kg of Evans blue dye was
injected through the internal jugular vein. At the time
of death after 8 hours of mechanical ventilation, the
lungs were perfused free of blood with 1 ml of 0.9%
normal saline via the right ventricle and removed en
bloc. Evans blue was extracted from lung tissue after
homogenization for 2 minutes in 5 ml of formamide
(Sigma Chemical, St. Louis, MO) and incubated at 37°C
overnight. The supernatant was separated by centrifuga-
tion at 5,000 g for 30 minutes, and the amount was
recorded. Evans blue in the plasma and lung tissue was
quantitated by dual-wave-length spectrophotometric
analysis at 620 and 740 nm. The method corrects the
specimen’s absorbance at 620 nm for the absorbance of
contaminating heme pigments, by using the following
formula: corrected absorbance at 620 = actual absor-
bance at 620 nm-[1.426 (absorbance at 740) + 0.03]. We
calculated the Evans blue dye amount extracted from
lung tissue and divided the amount by the weight of the
lung tissue.
Analysis of lung water
Lungs were removed en bloc, and large airways were
removed. Both lungs were weighed and then dried in an
oven at 80°C for 48 hours. If no changes were found in
the dry lung weight at 24 and 48 hours, the weight at 48
hours was used. Lung wet-to-dry weight ratio was used
as an index of pulmonary edema formation [16].
Myeloperoxidase Assay
The lungs (0.12 to 0.17 g) were homogenized in 5 ml of
phosphate buffer (20 mM, pH 7.4). One milliliter of the
homogenate was centrifuged at 10,000 g for 10 minutes
at 4°C. The resulting pellet was resuspended in 1 ml of
Table 1 Experimental design and numbers of animals per group
Control +
RA (WT)
Control +
O2 (WT)
VT 30 ml/kg +
RA (WT)
VT 30 ml/kg +
O2 (WT)
VT 30 ml/kg + O2 with
enoxaparin (WT)
VT 30 ml/kg +
O2 (Akt
+/-)
HMGB1, cell isolation
(8 hours of ventilation)
55 5 5 5 5
Phospho-Akt, HMGB1 mRNA (2, 4, 8
hours of ventilation)
55 5 × 3 5 × 3 5 5
MPO, lung edema
(8 hours of ventilation)
55 5 5 5 5
EBD assay (8 hours of ventilation) 5 5 5 5 5 5
MDA/GSH, IHC
(8 hours of ventilation)
55 5 5 5 5
Akt = serine/threonine kinase/protein kinase B; Akt
+/- = Akt deficient mice; Control = spontaneously breathing, nonventilated mice; EBD = Evans blue dye; GSH =
total glutathione; HMGB1 = high-mobility group box-1; IHC = immunohistochemical stain; MDA = malondialdehyde; MPO = myeloperoxidase; O2 = mice with
hyperoxia; RA = mice with room air; VT = tidal volume; WT: wild type.
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adecyltrimethylammonium bromide. The suspension
was then subjected to three cycles of freezing (on dry
ice) and thawing (at room temperature), after which it
was sonicated for 40 seconds and centrifuged again at
10,000 g for 5 minutes at 4°C. The supernatant was
assayed for MPO activity by measuring the hydrogen
peroxide (H2O2)-dependent oxidation of 3, 3’,5 ,5 ’-
tetramethylbenzidine (TMB). In its oxidized form, TMB
has a blue color, which was measured spectrophotome-
trically at 650 nm. The reaction mixture for analysis
consisted of a 25-μl tissue sample, 25 μlo fT M B( f i n a l
concentration 0.16 mM) dissolved in dimethylsulfoxide,
and 200 μlo fH 2O2 (final concentration 0.30 mM) dis-
solved in phosphate buffer (0.08 M, pH 5.4). The reac-
tion mixture was incubated for 3 minutes at 37°C and
the reaction was stopped by adding 1 ml of sodium
acetate (0.2 M, pH 3.0), after which absorbance at 650
nm was measured. The absorbance (A650) was reported
as optical density (OD)/g of wet lung weight [6].
Immunoblot analysis
The lungs were homogenized in 3 ml of lysis buffer (20
mM HEPES pH 7.4, 1% Triton X-100, 10% glycerol, 2 mM
ethylene glycol-bis (b-aminoethyl ether)-N, N, N’,N ’-tetra-
acetic acid, 50 μM b-glycerophosphate, 1 mM sodium
orthovanadate, 1 mM dithiotreitol, 400 μM aprotinin, and
400 μM phenylmethylsulfonyl fluoride), transferred to
eppendorff tubes and placed on ice for 15 minutes. Tubes
were centrifuged at 14,000 rpm for 10 minutes at 4°C and
supernatant was flash frozen. Crude cell lysates were
matched for protein concentration, resolved on a 10% bis-
acrylamide gel, and electrotransferred to Immobilon-P
membranes (Millipore Corp., Bedford, MA). For assay of
Akt phosphorylation and Akt total protein expression,
Western blot analyses were performed with antibodies of
phospho-Akt and Akt (New England BioLabs, Beverly,
MA). Blots were developed by enhanced chemilumines-
cence (NEN Life Science Products, Boston, MA).
Reverse transcription-polymerase chain reaction
For isolating total RNA, the lung tissues were homoge-
nized in TRIzol reagents (Invitrogen Corporation, Carls-
bad, CA) according to the manufacturer’s instructions.
Total RNA (1 μg) was reverse transcribed by using a
GeneAmp PCR system 9600 (PerkinElmer, Life Sciences,
Inc., Boston, MA), as previously described [16]. The fol-
lowing primers were used for PCR: HMGB1, forward pri-
mer 5’-TGGCAAAGGCTGACAAGGCTC-3’ and reverse
primer 5’-GGATGCTCGCCTTTGATTTTGG-3’ and
GAPDH as internal control, forward primer 5’-AATG-
CATCCTGCA CCACCAA-3’ and reverse primer 5’-
GTAGCCATATTCATTGTCATA-3’ (Integrated DNA
Technologies, Inc., Coralville, IA) [20].
Measurement of malondialdehyde and total glutathione
The lungs were homogenized in phosphate buffered sal-
ine containing butylated hydroxytoluene for MDA and
metaphosphoric acid for total glutathione. The malon-
dialdehyde and total glutathione in the protein extracts
were measured using the Oxiselect TBARS assay kit con-
taining thiobarbituric acid reactive substances and Oxise-
lect total glutathione assay kit containing glutathione
reductase (Cell Biolabs, San Diego, CA). Each sample was
run in duplicate and expressed as μmole/g protein for
MDA and μg/mg protein for total glutathione according
to the manufacturer’s instructions.
Measurement of HMGB1
At the end of the study period, the lungs were lavaged via
tracheostomy with 20-gauge angiocatheter (sham instilla-
tion) 3 times with 0.6 ml of 0.9% normal saline. The efflu-
ents were pooled and centrifuged at 2,000 rpm for 10
minutes. Supernatants were frozen at -80°C for further
analysis of the cytokine. HMGB1 with a lower detection
limit of 1 ng/ml was measured in bronchoalveolar lavage
fluid using a commercially available immunoassay kit con-
taining primary polyclonal anti-mouse antibody that was
cross-reactive with rat and mouse HMGB1 (Shino-Test
corporation, Kanagawa, Japan). Each sample was run in
duplicate according to the manufacturer’s instructions.
Immunohistochemistry
The lungs were paraffin embedded, sliced at 4 μm,
deparaffinized, antigen unmasked in 10 mM sodium
citrate (pH 6.0), incubated with rabbit phospho-Akt pri-
mary antibody (1:100; New England BioLabs, Beverly,
MA), and biotinylated goat anti-rabbit secondary anti-
body (1:100) according to the manufacturer’s instruction
for an immunohistochemical kit (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) [6].
Statistical Evaluation
The Western blots and HMGB1 mRNA were quantitated
using a National Institutes of Health (NIH) image analy-
zer, ImageJ 1.27z (National Institute of Health, Bethesda,
MD, USA) and presented as arbitrary units. Values were
expressed as the mean ± SD for at least 5 experiments.
The data of Evans blue dye (EBD) assay, lung wet-to-dry
weight ratio, HMGB1, myeloperoxidase (MPO), immuno-
histochemical assay, MDA, and total glutathione were
conducted by using Statview 5.0 (Abascus Concepts Inc.
Cary, NC, USA; SAS Institute, Inc.). All results of Western
blots and HMGB1 mRNA were normalized to control,
nonventilated mice with room air. ANOVA was used to
assess the statistical significance of the differences, fol-
lowed by multiple comparisons with a Scheffe’s test, and a
P value < 0.05 was considered statistically significant.
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regression test in Statview.
Results
Physiologic data
No statistical difference was found in pH, PaO2,P a C O 2,
mean arterial pressure, and peak inspiratory pressure at
the beginning versus the end of 8 hours of mechanical
ventilation (Table 2). The normovolemic statuses of mice
were maintained by monitoring mean artery pressure.
Inhibition of the effects of hyperoxia on lung stretch-
induced microvascular leak, oxygen radicals, neutrophil
sequestration, and HMGB1 production with enoxaparin
To determine the effects of hyperoxia on changes of
microvascular permeability and lung water in VILI, we
measured lung EBD and wet-to-dry weight ratio. The
levels of lung EBD and wet-to-dry weight ratio were sig-
nificantly increased in mice receiving VT 30 ml/kg
mechanical ventilation with hyperoxia compared with
those of control, nonventilated mice and mice ventilated
with room air at a VT of 30 ml/kg (Figure 1). To measure
the level of oxidant stress involved in hyperoxia-induced
ALI, we measured MDA and total glutathione levels
from lung tissues. Increased production of MDA but
reduced production of total glutathione was found in
mice ventilated at VT 30 ml/kg with hyperoxia compared
with those of control, nonventilated mice and mice venti-
lated with room air at a VT of 30 ml/kg (Figure 2). To
determine the effects of hyperoxia on neutrophils, a
potential source of reactive oxygen species marginated in
the vasculature, lung parenchyma, and in the alveoli, and
to determine the inflammatory cytokines for neutrophils,
we measured MPO activity and HMGB1 protein produc-
tion. The MPO levels and HMGB1 protein production in
mice ventilated with hyperoxia at VT 30 ml/kg were sig-
nificantly elevated compared with those of control, non-
ventilated mice and mice ventilated with room air at a
VT of 30 ml/kg (Figures 3). The increases in microvascu-
lar leak, lung edema, MPO levels, and HMGB1 produc-
tion in mice receiving VT 30 ml/kg mechanical
ventilation with hyperoxia were significantly reduced
after pharmacological inhibition with enoxaparin.
Reduced production of MDA but increased production
of total glutathione was found after pharmacological inhi-
bition with enoxaparin.
Inhibition of the effects of hyperoxia on lung stretch-
induced HMGB1 mRNA expression with enoxaparin
To determine whether the increased neutrophil influx in
mice receiving VT 30 ml/kg mechanical ventilation was
associated with upregulation of chemotactic factors for
neutrophils, we measured HMGB1 mRNA expression
for 2 to 8 hours of mechanical ventilation while breath-
ing room air or hyperoxia. The HMGB1 mRNA expres-
sion was increased at 2 hours of mechanical ventilation
with VT 30 ml/kg and remained elevated after 8 hours
of mechanical ventilation compared with those of con-
trol, nonventilated mice (Figures 4). The increases in
HMGB1 mRNA expression in mice receiving VT 30 ml/
kg mechanical ventilation with hyperoxia were signifi-
cantly reduced after pharmacological inhibition with
enoxaparin (Figure 5A). The reduction between VT 30
ml/kg mechanical ventilation using hyperoxia with and
without enoxaparin was more than those between VT 30
ml/kg mechanical ventilation with and without hyper-
oxia. This suggested that pharmacological inhibition
with enoxaparin reduced both effects of mechanical ven-
tilation and hyperoxia.
Inhibition of the effects of hyperoxia on lung stretch-
induced Akt activation with enoxaparin
We measured the activity of Akt in lung homogenate of
mice exposed to VT 30 ml/kg mechanical ventilation for
2 to 8 hours while breathing room air or hyperoxia to
determine the effects of hyperoxia on stretch-induced
Table 2 Physiologic conditions at the beginning and end of ventilation
Nonventilated
Room air
Nonventilated
Hyperoxia
VT 30 ml/kg
Room air
VT 30 ml/kg
Hyperoxia
PH 7.40 ± 0.05 7.37 ± 0.01 7.35 ± 0.04 7.34 ± 0.02
PaO2 (mmHg) 98.6 ± 0.3 423.5 ± 4.3 86.9 ± 0.7 399.7 ± 3.6
PaCO2 (mmHg) 39.1 ± 0.2 39.6 ± 0.7 37.3 ± 1.2 43.4 ± 1.5
MAP (mmHg)
Start 85.5 ± 1.2 85.9 ± 1.9 84.8 ± 1.5 84.5 ± 2.4
End 85.1 ± 0.6 84.9 ± 0.8 77.5 ± 3.0 77.3 ± 2.3
PIP (mmHg)
Start 24.3 ± 1.2 24.9 ± 1.3
End 27.7 ± 1.0 28.2 ± 1.3
Arterial blood gases and mean arterial pressure were obtained from nonventilated mice and mice ventilated at a tidal volume of 30 ml/kg for 8 hours (n = 10
per group). MAP = mean arterial pressure; PIP = peak inspiratory pressure; VT = tidal volume. The physiological data of control groups were similar during the
experiment and were used as the beginning data of mechanical ventilation. Because no differences were observed among hyperoxia with enoxaparin, without
enoxaparin, and Akt deficient groups, the data were combined.
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increases in the phosphorylation of Akt but there were
no significant changes in the expression of total non-
phosphorylated proteins of Akt. The activation of Akt
increased after 2 hours of mechanical ventilation with
VT 30 ml/kg and remained increased after 8 hours of
mechanical ventilation compared with those of control,
nonventilated mice (Figure 6). To further determine the
inflammatory cells involved in the hyperoxia-induced
Akt activation, we measured Akt activity in isolated neu-
trophils from lung tissue (Figure 7). The increases in
Akt activation in mice receiving VT 30 ml/kg
mechanical ventilation with hyperoxia were significantly
reduced after pharmacological inhibition with enoxa-
parin (Figure 5B and 7).
Akt deficient mice reduced the effects of hyperoxia on
ventilation-induced microvascular leak, Akt activation,
HMGB1 mRNA expression, neutrophil sequestration,
oxygen radicals, and HMGB1 production
To determine the role of Akt activation in hyperoxia-
augmented VILI, we used Akt deficient mice. The
effects of hyperoxia on the increases of microvascular
Figure 1 Enoxaparin and Akt deficient mice reduced hyperoxia-
augmented lung stretch-induced microvascular leak and lung
edema. Evans blue dye (EBD) analysis of lung tissue (A) and lung
water measured by lung wet-to-dry-weight ratio (B) were from control,
nonventilated mice and mice ventilated at tidal volume (VT)3 0m l / k g
(VT 30 ml) for 8 hours with room air or hyperoxia. Enoxaparin, 4 mg/kg,
was given subcutaneously 30 minutes before ventilation (n = 5 per
group). * P < 0.05 versus control, nonventilated mice; †P < 0.05 versus
all other groups. Akt
+/- = serine/threonine kinase/protein kinase (Akt)
deficient mice; LMWH = enoxaparin; RA = mice with room air.
Figure 2 Enoxaparin and Akt deficient mice reduced the
effects of hyperoxia on lung stretch-induced oxidant stress.
Malondialdehyde (MDA) assay (A) and total glutathione (GSH) assay
(B) of lung tissue were from control, nonventilated mice and mice
ventilated at VT 30 ml/kg for 8 hours with room air or hyperoxia.
Enoxaparin, 4 mg/kg, was given subcutaneously 30 minutes before
ventilation (n = 5 per group). * P < 0.05 versus control,
nonventilated mice; †P < 0.05 versus all other groups. Akt
+/- = Akt
deficient mice; LMWH = enoxaparin; RA = mice with room air.
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sion, Akt activation in whole lung homogenate and iso-
lated neutrophils from lung tissue, and HMGB1
production in mice receiving VT 30 ml/kg mechanical
ventilation were significantly reduced with Akt deficient
mice (Figure 1, 3, 5, and 7). Reduced production of
MDA but increased production of total GSH was found
in Akt deficient mice (Figure 2). The reduction between
VT 30 ml/kg mechanical ventilation using hyperoxia
with and without Akt deficient mice was more than
those between VT 30 ml/kg mechanical ventilation with
and without hyperoxia. This suggested that Akt deficient
mice reduced both effects of mechanical ventilation and
hyperoxia. With immunohistochemistry, we further con-
firmed the effectiveness of enoxaparin in the inhibition
of HMGB1 production and activation of Akt signaling
Figure 3 Enoxaparin and Akt deficient mice reduced hyperoxia-
augmented lung stretch-induced neutrophil sequestration and
HMGB1 production. Myeloperoxidase (MPO) assay of lung tissue (A)
and high-mobility group box-1 (HMGB1) production in
bronchoalveolar lavage (BAL) fluid (B) were from control, nonventilated
mice and mice ventilated at VT 30 ml/kg for 8 hours with room air or
hyperoxia. Enoxaparin, 4 mg/kg, was given subcutaneously 30 minutes
before ventilation (n = 5 per group). * P < 0.05 versus control,
nonventilated mice; †P < 0.05 versus all other groups. Akt
+/- =A k t
deficient mice; LMWH = enoxaparin; RA = mice with room air.
Figure 4 High tidal volume ventilation caused a time-
dependent increase on HMGB1 mRNA expression. Reverse
transcription-polymerase chain reaction (RT-PCR) assay was
performed for HMGB1 mRNA (A and B, top panel), glyceraldehydes-
phosphate dehydrogenase (GAPDH) mRNA (A and B, middle panel),
and arbitrary units (A and B, bottom panel) from control,
nonventilated mice and mice ventilated with VT 30 ml/kg breathing
room air or hyperoxia at indicated time periods (n = 5 per group).
Arbitrary units were expressed as the ratio of HMGB1 mRNA to
GAPDH. * P < 0.05 versus control, nonventilated mice. O2 = mice
with hyperoxia; RA = mice with room air.
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inflammation in bronchial epithelial cells (Figure 8).
Discussion
Mechanical ventilation with hyperoxia, both in the early
and late fibroproliferative stages of ALI, is often
required to prevent hypoxemia in patients with ARDS.
Prolonged exposure to hyperoxia may lead to excessive
production of reactive oxygen species, which are
generated by neutrophils, macrophages, and airway
epithelial cells [21]. In a previous in vivo mouse study of
ALI, we found that hyperoxia increased high VT-induced
lung inflammation and production of MIP-2 chemoat-
tractant, a functional homolog of human interleukin
(IL)-8 belonging to the cysteine-amino-cysteine family
of cytokines [6]. On exposure to hyperoxia, excessive
reactive oxygen species act as direct cell toxins and as
secondary messengers by inducing pulmonary epithe-
lium to secrete chemoattractants and proinflammatory
cytokines that lead to influx of neutrophils to the lung
[21]. In the present mouse model of VILI, we found that
hyperoxia increased high VT-induced lung edema,
microvascular permeability, neutrophil infiltration, and
free radical production. High tidal volumes in normal
animals have been used to mimic overdistention of the
Figure 5 Enoxaparin and Akt deficient mice reduced hyperoxia-
augmented lung stretch-induced HMGB1 mRNA expression and
Akt activation. Wild-type or Akt
+/- mice were ventilated at VT
30 ml/kg for 2 hours with room air or hyperoxia. Enoxaparin, 4 mg/kg,
was given subcutaneously 30 minutes before ventilation. (A) RT-PCR
assay was performed for HMGB1 mRNA (A, top panel), GAPDH mRNA
(A, middle panel), and arbitrary units (A, bottom panel). Arbitrary units
were expressed as the ratio of HMGB1 mRNA to GAPDH (n = 5 per
group). (B) Western blot was performed using an antibody that
recognizes the phosphorylated Akt expression (B, top panel) and an
antibody that recognizes total Akt protein expression in lung tissue
homogenate (B, middle panel). Arbitrary units were expressed as
relative Akt phosphorylation (B, bottom panel) (n = 5 per group). * P <
0.05 versus control, nonventilated mice; †P < 0.05 versus all other
groups. Akt
+/- = Akt deficient mice; LMWH = enoxaparin; O2 =m i c e
with hyperoxia; RA = mice with room air.
Figure 6 High tidal volume ventilation caused a time-dependent
increase on Akt activation. Western blot was performed using an
antibody that recognizes the phosphorylated Akt expression (A and B,
top panel) and an antibody that recognizes total Akt protein
expression in lung tissue homogenate (A and B, middle panel) from
control, nonventilated mice, and mice ventilated with VT 30 ml/kg
breathing room air or hyperoxia at indicated time periods. Arbitrary
units were expressed as relative Akt phosphorylation (A and B, bottom
panel) (n = 5 per group). * P < 0.05 versus control, nonventilated mice.
O2 = mice with hyperoxia; RA = mice with room air.
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found in ARDS patients. We explored further the roles
of neutrophils and Akt activation in hyperoxia-augmen-
ted lung injury and production of HMGB1, a lethal
mediator of severe sepsis.
Hyperoxia-induced lung injury is characterized by
overwhelming diffuse inflammation, pulmonary edema,
destruction of alveolar-capillary barrier, and loss of lung
compliance [5]. In a previous study of rats, we found
the addition of oxygen to the rats ventilated at VT 20
ml/kg markedly increased the bronchoalveolar fluid con-
tent of neutrophils [2]. Neutrophils are the major
inflammatory cells involved in the process of acute lung
injury and play a major role in the generation of reactive
oxygen species [8]. In the present study, we isolated
neutrophils from lung tissues and found mechanical
ventilation with hyperoxia significantly increased the
activation of Akt signaling.
HMGB1 has been shown to be a late onset biomarker
of lethal systemic inflammation, which distinguishes it
from the early acting mediators of IL-8, IL-1b,a n d
TNF-a [9]. There are three HMGB nonhistone chromo-
somal proteins: HMGB1 (previously HMG1), HMGB2
(previously HMG2), and HMGB3 (previously HMG4 or
HMG2). HMGBs are composed of three different
domains, including homologous DNA binding boxes A
and B in the N-terminus and the C-terminal domain
[22]. HMGB1 appears to have two distinct functions in
cellular systems, as an intracellular regulator of tran-
scription and an extracellular inflammatory cytokine
[22]. A previous study of ALI in mice pretreated with
HMGB1 showed that lung inflammation with neutrophil
accumulation and local production of proinflammatory
cytokines, including IL-1b,T N F - a, and MIP-2 [23]. We
found that hyperoxia increased mechanical ventilation-
induced influx of neutrophils and HMGB1 production.
Reduced levels of glutathione have been found in the
alveolar fluid of patients with ARDS [8]. In our study,
high-tidal-volume mechanical ventilation with hyperoxia
increased the levels of malondialdehyde, an aldehydic
secondary product of lipid peroxidation used as a mar-
ker of oxidative damage and decreased the levels of glu-
tathione, the most abundant non-protein thiol
functioning as an endogenous scavenger of reactive oxy-
gen species in the presence of glutathione peroxidase by
reducing hydrogen peroxide or other hydroperoxides to
less toxic substances [24,25]. In a study of injurious
mechanical ventilation in rabbits, bronchoalveolar lavage
fluid levels of HMGB1 were 5-fold higher after 4 hours
of mechanical ventilation with large tidal volumes com-
pared with those of lower tidal volumes [10]. We found
that hyperoxia with production of free radicals and
recruitment of neutrophils augmented high VT-induced
HMGB1 mRNA expression and HMGB1 production.
Heparin was shown to modulate infiltration of neutro-
phils and improve gas exchange and severity of hyaline
membrane formation [26,27]. An in vitro study of
endothelia demonstrated that HMGB1 interacted in a
complex manner with the hemostatic system and PAI-1
was important for HMGB1 to exert its effects [28]. Our
previous murine study of ALI showed that enoxaparin
reduced high-tidal-volume ventilation-induced PAI-1
production, an early mediator of acute pulmonary
inflammation [16]. In the present study, we demon-
strated further that hyperoxia increased high tidal
volume ventilation-induced HMGB1 mRNA expression
and HMGB1 production, a late mediator of lung inflam-
mation, in a short duration of mechanical ventilation.
Pharmacological inhibition with enoxaparin reduced the
levels of HMGB1 involved in ALI. Previous study of
high-tidal-volume mechanical ventilation using hyper-
oxia in mice showed that Akt signaling in lung epithelial
cells regulated neutrophil migration into the injured
lungs [29]. In an in vitro study of human neutrophils,
others showed that HMGB1 increased nuclear transloca-
tion of nuclear factor-appa-B and expression of proin-
flammatory cytokines among neutrophils through
activation of p38, extracellular signal-regulated kinase 1/
2, and PI 3-K/Akt [22,30]. In our murine study, we
found hyperoxia augmented high VT-induced neutrophil
Figure 7 Enoxaparin and Akt deficient mice reduced hyperoxia-
augmented lung stretch-induced Akt activation in neutrophils.
Wild-type or Akt
+/- mice were ventilated at VT 30 ml/kg for 2 hours
with room air or hyperoxia. Enoxaparin, 4 mg/kg, was given
subcutaneously 30 minutes before ventilation. Western blot from
isolated neutrophils of lung tissue was performed using an antibody
that recognizes the phosphorylated Akt expression (top panel) and an
antibody that recognizes total Akt protein expression in lung tissue
(middle panel). Arbitrary units were expressed as relative Akt
phosphorylation (bottom panel) (n = 5 per group). * P < 0.05 versus
control, nonventilated mice; †P < 0.05 versus all other groups. Akt
+/- =
Akt deficient mice; LMWH = enoxaparin; O2 = mice with hyperoxia; RA
= mice with room air.
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Page 9 of 12Figure 8 Enoxaparin and Akt deficient mice reduced hyperoxia-augmented lung stretch-induced Akt activation in airway epithelium.
Representative photomicrographs (x400) with phospho-Akt staining of paraffin lung sections with immunohistochemistry were from control,
nonventilated mice and mice ventilated at VT 30 ml/kg for 8 hours with room air or hyperoxia. Enoxaparin, 4 mg/kg, was given subcutaneously
30 minutes before ventilation (n = 5 per group). (A) Control wild-type mice with room air; (B) Control wild-type mice with hyperoxia; (C) VT 30
ml/kg wild-type mice with room air; (D) VT 30 ml/kg wild-type mice with hyperoxia; (E) VT 30 ml/kg wild-type mice pretreated with 4 mg/kg
enoxaparin breathing hyperoxia; (F) VT 30 ml/kg Akt deficient mice with hyperoxia. A dark brown diaminobenzidine (DAB) signal identified by
arrows indicates positive staining for phospho-Akt in the lung epithelium or interstitial, whereas shades of bluish tan signify nonreactive cells. * P
< 0.05 versus control, nonventilated mice; †P < 0.05 versus all other groups. Scale bars represent 20 μm. Akt
+/- = Akt deficient mice; LMWH =
enoxaparin; RA = mice with room air.
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expression, Akt activation in bronchial epithelium and
neutrophils, and HMGB1 production. These effects were
significantly reduced with Akt deficient mice. HMGB1
-/-
mice are not used in this study because they die shortly
after birth due to a defect in the transcriptional activa-
tion of the glucocorticoid receptor, consistent with the
notion that HMGB1 functions as a regulator of tran-
scription involving steroid hormone receptors [31].
Findings in other study supported our results that
neutrophil infiltration and the development of acute
lung injury involved the Akt pathway through toll-like
receptors (TLR) 4-dependent activation of nicotinamide
adenine dinucleotide phosphate oxidase and reactive
oxygen species production in a mouse model of hemor-
rhagic shock and resuscitation [32]. HMGB1-mediated
neutrophil activation occurs through TLR2, TLR4, and
advanced glycation end products while LPS-induced sig-
nals through TLR4 [33]. The heterogeneity of peptides
that interact with HMGB1 indicates that HMGB1 does
not have a highly preferred interaction sequence and is
capable of associating with multiple proteins [34]. Our
study does have limitation that we don’t compare the
differences between different sexes [35]. Incorporation
of hormone variations in further experiments may
explore more about whether male and female mice are
equally susceptible to VILI.
Conclusion
Though the ARDS network trial demonstrated that low-
tidal-volume ventilation is safer than high-tidal-volume
ventilation, these findings have been questioned and the
mechanisms of injury and protection need to be further
examined [36]. The National Heart, Lung and Blood
Institute working group on acute lung injury identified
examination of the biology of stress-induced injury to the
lung in health and disease as a fertile area of future
research, because ventilation-induced release of cytokines
may lead to systemic translocation and multisystem
organ failure [37]. High tidal volumes in normal animals
have been used to mimic overdistention of the less
injured and thus more compliant areas of lung found in
ARDS patients. These animal models have shown that
simply over overdistending lung tissue, in the absence of
acid aspiration or bacterial lipopolysaccharide causes pro-
duction of cytokines and chemokines [3,38,39]. In clinical
practice after intubations, patients are often ventilated
initially with high levels of tidal volume and oxygen (frac-
tion of inspired oxygen of more than or equal to 50%) to
oxygenate the brain and other vital organs. Using an in
vivo m o u s em o d e l ,w eh a v ef o u n dt h a th y p e r o x i a
increased high-tidal-volume ventilation-induced epithe-
lial cell injury, resulted in increased pulmonary neutro-
phil sequestration, oxidant stress, and increased HMGB1
production. The deleterious effects were attenuated by
low-dose enoxaparin treatment and were, at least in part,
dependent on the Akt pathway. Our data suggest that
effects of high-tidal-volume ventilation and hyperoxia on
lung inflammation occur in the first few hours of VILI.
Understanding the protective mechanism of low-dose
enoxaparin related with the regulation of HMGB1 and
Akt signaling may advance the growing knowledge of
biomarkers to be monitored in the course of ALI and the
effects of mechanical forces in the lung involved in the
pathogenesis of biotrauma with hyperoxia.
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